StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a report released on Tuesday. The firm set a “sell” rating on the stock.
Ayala Pharmaceuticals Stock Performance
Shares of Ayala Pharmaceuticals stock opened at $0.02 on Tuesday. The firm has a fifty day simple moving average of $0.18 and a 200-day simple moving average of $0.47. The stock has a market capitalization of $852,660.00, a price-to-earnings ratio of 0.00 and a beta of 1.56. Ayala Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $1.49.
Ayala Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ayala Pharmaceuticals
- 3 Warren Buffett Stocks to Buy Now
- What Are Bonds? A High-Level Overview
- 3 Small Caps With Big Return Potential
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- Why is the Ex-Dividend Date Significant to Investors?
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.